John Frederick Ek, Chief Financial Officer at GenMark Diagnostics, Inc. (GNMK), sold 66,754 shares at $15.97 ($1.1M) on 2020-08-14, disclosed to the SEC on 2020-08-18.
Open-market sale of $1.1M GNMK by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.97 | 5,070 | $81K | 7.6% |
| 2 | $15.97 | 5,070 | $81K | 7.6% |
| 3 | $15.98 | 28,307 | $452K | 42.4% |
| 4 | $15.98 | 28,307 | $452K | 42.4% |
| Total | $15.98 avg | 66,754 | $1.1M | 100% |
| Filing → |
| GNMK | SELL | 2020-11-25 | $19K | — | Filing → |
| GNMK | SELL | 2020-11-20 | $23K | — | Filing → |
| GNMK | SELL | 2020-09-24 | $1.1M | — | Filing → |